Top Healthcare and Biotech Focused Hedge Funds Oversee $43 Billion in Equity Assets

July 6th, 2013
| More
The Top 50 Healthcare, Pharmaceutical and Biotechnology Focused Hedge Fund list has been released, revealing that the top hedge funds now manage $43 billion in U.S. equity assets. The top 50 hedge funds allocate $29.8 billion, or 69% of their total equity assets, to Healthcare, Pharma & Biotech stocks.

The Top Healthcare, Pharma & Biotech Hedge Fund List is led by #1 Larry Robbins’ Glenview Capital Management and #2 Samuel Isaly‘s OrbiMed Advisors. The two top funds swapped spots on this quarter’s list, as OrbiMed Advisors had most recently been ranked #1, while Glenview Capital was #2 on the 12/31/2012 ranking. While Isaly’s OrbiMed Advisors is purely a healthcare focused investor, Robbins’ Glenview Capital is a global long/short equity investor that opportunistically makes big sector bets.

Some notable hedge funds at the top of the hedge fund list include #5 Healthcor Partners and #8 Palo Alto Investors. New York City-based Healthcor Partners is a healthcare focused hedge fund manager that is led by portfolio managers Arthur Cohen and Joseph Healey. The firm, which was originally a part of SAC Capital Advisors, reported having U.S. equity assets of $2.1 billion, dedicating 85.6% of its assets to Healthcare, Pharma & Biotech equities.

William Edwards’ growth focused Palo Alto Investors reported U.S. equity assets of $844 million, dedicating 100% of its assets to Healthcare, Pharma & Biotech equities. The California-based firm focuses on healthcare and biotech stocks, typically concentrating its portfolio on 30 to 40 top stocks.

Ranking Methodology: The Top Healthcare, Pharmaceutical and Biotechnology Hedge Fund rankings are compiled on a quarterly basis using hedge fund firms’ overall U.S. equity assets under management. The list includes the top hedge funds that have more than 35% of their U.S. equity assets invested in U.S. listed Healthcare, Pharma & Biotech companies, as of 12/31/2012. To view the Top Healthcare, Pharma & Biotech Hedge Fund list in its entirety, please visit HedgeTracker’s Hedge Fund Portal.
For Detailed Investor Profiles on these Investors, click below:
Glenview Capital Management
Healthcor Partners
OrbiMed Advisors
Palo Alto Investors
Related People: Arthur Cohen; Dr. Anthony Yun; Joseph Healey; Larry Robbins; Samuel Isaly; William Edwards
Related Entities: Caduceus Asia Partners LP; Caduceus Capital LP; Eaton Vance Worldwide Health Sciences; Finsbury Worldwide Pharmaceutical; GCM Little Arbor Institutional Partners; GCM Little Arbor Master; GCM Little Arbor Partners; Glenview Capital Master; Glenview Capital Partners; Glenview Institutional Partners; Healthcor Management LP; OrbiMed Associates; OrbiMed Capital; Palo Alto Global Energy Fund LP; Palo Alto Healthcare Fund LP; Palo Alto Small Cap Fund LP; Palo Alto Technology Fund; SAC Capital Advisors*
Related Article Tags: Multi-Strategy, Long Short, Equity, Debt and Global Macro Hedge Fund News; Featured Reports


More Recent Headlines

Former UBS Hedge Fund Manager Expands MST Capital’s Reach in Asia-Pacific

Dinakar Singh’s TPG-Axon Capital ousts SandRidge Energy’s CEO

Top New York Hedge Funds see assets jump by 21% YTD; Two Sigma & Renaissance Technologies surge

AIFMD – What you should be doing to comply (Part II)

Daniel Loeb’s Third Point LLC Longs for Less Short Positions

Omega Advisors’ Leon Cooperman to deliver 2013 Stock Picks

Kingdon Capital veteran Geoff Swerdlin forms Partes Capital Management

Scout Capital Management’s Appetite for Activism Grows with Restaurant Stakes

Glenview Capital Management and Jana Partners push for Board Makeover at Health Management Associates

FRM enters into strategic relationship with CommEq Asset Management